ArriVent BioPharma Inc. C... (AVBP)
ArriVent BioPharma Common Stock Max Pain By Strike
AVBP trades at $19.84, 11.8% below the near-term max pain of $22.5 expiring Oct 17, 2025 (11 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is falling across expirations ($2.5-$22.5), signaling increased put positioning or downside protection. Key magnetic zone at 23 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
ArriVent BioPharma Common Stock Max Pain By Expiry
Max pain for AVBP shows a downward trend from 22.5 to 2.5, indicating bearish sentiment or hedging activity. The 119% spread signals divergent expectations across timeframes. Most levels above 19.84 could support dips. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Oct 17, 2025 | 22.5 | n/a (n/a) |
| Nov 21, 2025 | 2.5 | n/a (n/a) |
| Jan 16, 2026 | 22.5 | n/a (n/a) |
| Apr 17, 2026 | 20 | n/a (n/a) |